Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Enveric Biosciences, Inc. (ENVB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2126-0.0017 (-0.79%)
At close: 04:00PM EDT
0.2130 +0.00 (+0.19%)
After hours: 07:58PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close0.2143
Open0.2021
Bid0.2130 x 800
Ask0.2250 x 900
Day's Range0.2021 - 0.2200
52 Week Range0.1700 - 3.7400
Volume1,061,770
Avg. Volume1,953,627
Market Cap11.201M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.6670
Earnings DateAug 11, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateApr 23, 2008
1y Target Est0.65
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ENVB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Enveric Biosciences, Inc.
    Daily – Vickers Top Buyers & Sellers for 07/01/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • PR Newswire

    Enveric Biosciences to Participate in Upcoming Conferences in June 2022

    Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric, will participate in three upcoming conferences:

  • PR Newswire

    Enveric Biosciences to Participate in the Microdose Psychedelic Capital Conference on May 26, 2022

    Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Avani Kanubaddi, President and Chief Operating Officer of Enveric, will participate virtually in Microdose's Psychedelic Capital: May 2022 Conference to be held virtually on May 26, 2022.

  • PR Newswire

    Enveric Biosciences to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022

    Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced that Dr. Joseph Tucker, Chief Executive Officer of Enveric, will participate virtually in the H.C. Wainwright Global Investment Conference to be held on May 23-26, 2022.

Advertisement
Advertisement